Filariasis asymptomatically infected donors have lower levels of disialylated IgG compared to endemic normals

Parasite Immunology

Volumn 36, Issue 12, 2014, Pages 713-720

  O'Regan, N L ^a   Steinfelder, S ^a   Schwedler, C ^b   Rao, G B ^c   Srikantam, A ^c   Blanchard, V ^b   Hartmann, S ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c LEPRA Society   (India)

Author keywords

Fc receptors; Filariasis; Human; Immune modulation; Immunoglobulin; Wuchereria bancrofti parasite

Indexed keywords

WUCHERERIA BANCROFTI;

GLYCOSYLATED IGG; IMMUNOGLOBULIN G; N ACETYLNEURAMINIC ACID;

ADULT; ANIMAL; ASYMPTOMATIC DISEASE; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; LYMPHATIC FILARIASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; WUCHERERIA BANCROFTI;

ADULT; ANIMALS; ASYMPTOMATIC DISEASES; ELEPHANTIASIS, FILARIAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; WUCHERERIA BANCROFTI;

EID: 84911864633     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12137     Document Type: Article

References (52)

1. Babu S, Bhat SQ, Pavan Kumar N, et al. Filarial lymphedema is characterized by antigen-specific Th1 and th17 proinflammatory responses and a lack of regulatory T cells. PLoS Negl Trop Dis 2009; 3: e420.
2. Hussain R, Hamilton RG, Kumaraswami V & Adkinson NF Jr, Ottesen EA. IgE responses in human filariasis. I. Quantitation of filaria-specific IgE. J Immunol 1981; 127: 1623-1629.
3. Pfarr KM, Debrah AY, Specht S & Hoerauf A. Filariasis and lymphoedema. Parasite Immunol 2009; 31: 664-672.
4. Taylor MJ, Hoerauf A & Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet 2010; 376: 1175-1185.
5. King CL, Mahanty S, Kumaraswami V, et al. Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest 1993; 92: 1667-1673.
6. Anuradha R, George PJ, Hanna LE, et al. Expansion of parasite-specific CD4 + and CD8 + T cells expressing IL-10 superfamily cytokine members and their regulation in human lymphatic filariasis. PLoS Negl Trop Dis 2014; 8: e2762.
7. Babu S, Kumaraswami V & Nutman TB. Alternatively activated and immunoregulatory monocytes in human filarial infections. J Infect Dis 2009; 199: 1827-1837.
8. Maizels RM & Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003; 3: 733-744.
9. Adjobimey T & Hoerauf A. Induction of immunoglobulin G4 in human filariasis: an indicator of immunoregulation. Ann Trop Med Parasitol 2010; 104: 455-464.
10. Harris N & Gause WC. To B or not to B: B cells and the Th2-type immune response to helminths. Trends Immunol 2011; 32: 80-88.
11. Hussain R, Grogl M & Ottesen EA. IgG antibody subclasses in human filariasis. Differential subclass recognition of parasite antigens correlates with different clinical manifestations of infection. J Immunol 1987; 139: 2794-2798.
12. Ottesen EA, Skvaril F, Tripathy SP, Poindexter RW & Hussain R. Prominence of IgG4 in the IgG antibody response to human filariasis. J Immunol 1985; 134: 2707-2712.
13. Kurniawan A, Yazdanbakhsh M, van Ree R, et al. Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis. J Immunol 1993; 150: 3941-3950.
14. Anthony RM, Wermeling F & Ravetch JV. Novel roles for the IgG Fc glycan. Ann N Y Acad Sci 2012; 1253: 170-180.
15. Nimmerjahn F & Ravetch JV. Fc-receptors as regulators of immunity. Adv Immunol 2007; 96: 179-204.
16. Collin M & Ehlers M. The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies. Exp Dermatol 2013; 22: 511-514.
17. Rombouts Y, Ewing E, van de Stadt LA, et al. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. doi: 10.1136/annrheumdis-2013-203565. [Epub ahead of print].
18. Schwedler C, Kaup M, Petzold D, et al. Sialic acid methylation refines capillary electrophoresis laser-induced fluorescence analyses of immunoglobin G N-glycans of ovarian cancer patients. Electrophoresis 2014; 35: 1025-1031.
19. Collins ES, Galligan MC, Saldova R, et al. Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment. Rheumatology 2013; 52: 1572-1582.
20. van de Geijn FE, Wuhrer M, Selman MH, et al. Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res Ther 2009; 11: R193.
21. Kaneko Y, Nimmerjahn F & Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006; 313: 670-673.
22. Samuelsson A, Towers TL & Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001; 291: 484-486.
23. Schwab I & Nimmerjahn F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol 2013; 13: 176-189.
24. Chen G, Wang Y, Qiu L, et al. Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer. J Proteomics 2012; 75: 2824-2834.
25. Anumula KR. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc. J Immunol Methods 2012; 382: 167-176.
26. Holland M, Yagi H, Takahashi N, et al. Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim Biophys Acta 2006; 1760: 669-677.
27. Huhn C, Selman MH, Ruhaak LR, Deelder AM & Wuhrer M. IgG glycosylation analysis. Proteomics 2009; 9: 882-913.
28. Berger M, Kaup M & Blanchard V. Protein glycosylation and its impact on biotechnology. Adv Biochem Eng Biotechnol 2012; 127: 165-185.
29. Guttman A. High-resolution carbohydrate profiling by capillary gel electrophoresis. Nature 1996; 380: 461-462.
30. Mechref Y & Novotny MV. Glycomic analysis by capillary electrophoresis-mass spectrometry. Mass Spectrom Rev 2009; 28: 207-222.
31. Szabo Z, Guttman A, Rejtar T & Karger BL. Improved sample preparation method for glycan analysis of glycoproteins by CE-LIF and CE-MS. Electrophoresis 2010; 31: 1389-1395.
32. Vanderschaeghe D, Szekrenyes A, Wenz C, et al. High-throughput profiling of the serum N-glycome on capillary electrophoresis microfluidics systems: toward clinical implementation of GlycoHepatoTest. Anal Chem 2010; 82: 7408-7415.
33. Adamczyk B, Tharmalingam-Jaikaran T, Schomberg M, et al. Comparison of separation techniques for the elucidation of IgG N-glycans pooled from healthy mammalian species. Carbohydr Res 2014; 389: 174-185.
34. Raju TS, Briggs JB, Borge SM & Jones AJ. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 2000; 10: 477-486.
35. Mittermayr S, Bones J, Doherty M, Guttman A & Rudd PM. Multiplexed analytical glycomics: rapid and confident IgG N-glycan structural elucidation. J Proteome Res 2011; 10: 3820-3829.
36. Parekh RB, Dwek RA, Sutton BJ, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 316: 452-457.
37. Nimmerjahn F, Anthony RM & Ravetch JV. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Natl Acad Sci USA 2007; 104: 8433-8437.
38. Arndts K, Deininger S, Specht S, et al. Elevated adaptive immune responses are associated with latent infections of Wuchereria bancrofti. PLoS Negl Trop Dis 2012; 6: e1611.
39. Atmadja AK, Atkinson R, Sartono E, et al. Differential decline in filaria-specific IgG1, IgG4, and IgE antibodies in Brugia malayi-infected patients after diethylcarbamazine chemotherapy. J Infect Dis 1995; 172: 1567-1572.
40. Jaoko WG, Simonsen PE, Meyrowitsch DW, et al. Filarial-specific antibody response in East African bancroftian filariasis: effects of host infection, clinical disease, and filarial endemicity. Am J Trop Med Hyg 2006; 75: 97-107.
41. Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010. Releve epidemiologique hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations. 2011; 86:377-388.
42. Working to overcome the global impact of neglected tropical diseases - Summary. Releve epidemiologique hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations. 2011; 86:113-120.
43. Dong X, Storkus WJ & Salter RD. Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. J Immunol 1999; 163: 5427-5434.
44. Malhotra R, Wormald MR, Rudd PM, et al. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995; 1: 237-243.
45. Shade K-TC & Anthony RM. Antibody glycosylation and inflammation. Antibodies 2013; 2: 392-414.
46. Anthony RM & Nimmerjahn F. The role of differential IgG glycosylation in the interaction of antibodies with FcgammaRs in vivo. Curr Opin Organ Transplant 2011; 16: 7-14.
47. Anthony RM & Ravetch JV. A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs. J Clin Immunol 2010; 30(Suppl 1): S9-S14.
48. Klaver EJ, Kuijk LM, Laan LC, et al. Trichuris suis-induced modulation of human dendritic cell function is glycan-mediated. Int J Parasitol 2013; 43: 191-200.
49. van Liempt E, van Vliet SJ, Engering A, et al. Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol Immunol 2007; 44: 2605-2615.
50. Bakovic MP, Selman MH, Hoffmann M, et al. High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. J Proteome Res 2013; 12: 821-831.
51. Selman MH, de Jong SE, Soonawala D, et al. Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination. Mol Cell Proteomics 2012; 11: M111-M014563.
52. Stadlmann J, Weber A, Pabst M, et al. A close look at human IgG sialylation and subclass distribution after lectin fractionation. Proteomics 2009; 9: 4143-4153.